NOVAVAX (Some Wild Prediction )This is a trend that I have drawn a while ago! Too bad that I did not publish as its wild and aggressive.
NVV1 trade ideas
Fib looks good for the near futureFibonacci looks good for the short term.
I think it will have a nice gap up soon.
LONG
My take on NVAXNVAX should hit my $300 target. Technicals with fundamentals mixed in. Thanks for watching and I'm interested in hearing your educated thoughts.
NVAX (1h Time Frame)Looking for price to give us a pullback into the $130 support (potential selling opportunities) but if we break to the upside @ $151.50, the closure would be what I need to then look at going long. I'm eyeing the $177-$182.50 for TP. #TechnicalAnalysis #Fibonacci
Novovax could see gains after COVID-19 vaccine orders roll in90 million vaccines have just been purchased by the UK government and the US is also in talks to purchase COVID-19 vaccines.
NVAX PT swing $177over $154 and I'm looking to take this to $177. $110 was the bottom. First Pt is $168 but the overall move is to $177 for the swing.
NVAX LONG D1 (extra entry)📈 LON G D1
🛒Risky entry (1%-2% risk) ~ 178.5
🛒A more reliable entry (2%-3% risk) = above 190.30
🎯Target1 = 209.5
🎯Target2 = 240.80
🛑Stop loss or cancel trade = 159
WHOOOO WHEEEE - JPM Calling NVAX To 275 Today On Drug DataThis is one of the more insane calls I've seen of late. Last night NVAX released drug data which was interpreted as a huge positive, and thus the stock is rallying this morning, especially following a JPM call that the company's fair value is $275. That's quite a bit of headroom from where we are now, and also about 70% upside from yesterday's close. A quick look at the momentum suggests that we might actually get there, but personally I'm skeptical. I'm not convinced that the winner of the Covid - 19 virus race will actually rake in profits from it, given how political finding the cure is, and how it seems unlikely that it will be sold for anything but at cost, probably around $10. Just some speculation. Definitely a situation to keep an eye on though. I''m looking for a slowing in momentum before shorting it.
[NVAX] Novavax: Preliminary studies produce promising resultsPreliminary studies on coronavirus vaccines have produced promising results.
I'm still a believer in their technology. Check out my previous NVAX posts and/or the first one. They have a promising technology that could revolutionize the vaccine industry. We (humanity) are already very behind in how we produce vaccines AKA using chicken eggs. So Novavax will hopefully pave the way for vaccines going forward.
Things to watch even after COVID-19:
- NanoFlu™
- ResVax™
- Recombinant Nanoparticle Vaccine Technology
- Matrix-M™ Adjuvant Technolog
TL;DR - To the moon and (probably) back lol
*Note: This is pure speculation and my own opinion*
NY Times: www.nytimes.com
CNBC: www.cnbc.com
NVAX LONG📈 NVAX LONG D1
🛒BUY above = 156
🎯Target1 = 172
🎯Target2 = 201
🛑Stop loss = 1126
🙈Risk = (1%-2%)
#NVAX #NVAXLONG #BUYNVAX
highly volatilehave upcoming earnings
double topped
below vwap
support at 9ema
expecting break to retest bullish channel
entry 100.28
stop loss 95
target >109
Risk/Reward -5/>+9
Novamax Inc (NVAX - NASDAQ) - Bulls in driving seat Novamax Inc (NVAX - NASDAQ) is in 3rd subwave of impulse sequence, where log scale is used to understand the wave structure. It is in 3rd internal wave of 3rd subwave of impulse. Buy in three wave pull back in appropriate waves. The gap in price with huge volume driving it up crazy.
$NVAX rising wedge forming on the dailyThere is a rising wedge forming on $NVAX daily chart. Bio stocks could break out to the topside with any news but this is a very bearish reversal pattern. Look for a play when it breaks the trend either way. Gap to the lower end could be filled.
NVAX'S VACCINE FOR FLU IS PROMISING! Hello traders!
Good news from Novavax! The chances of approval for flu vaccine candidate NanoFlu seems actually quite good!
Moreover, if we look at the chart, we can see that the price is on a strong uptrend that doesn't seem to want to stop. The bullish momentum is still strong!
Remember to put a stop loss in order to secure your capital!
Not a financial advice.
Enjoy your trade!
NOVAVAX announcementHey guys, NOVAVAX is in a compression zone, sinal to purchase high volume of sales in recent days. It may break the balance area from above at the same time, great hope of breaking out the second area while passing.
Please LIKE & FOLLOW, thank you!
Novavax Announces $1.6 Billion Funding from Operation Warp SpeedNovavax Announces $1.6 Billion Funding from Operation Warp Speed
has been selected to participate in Operation Warp Speed (OWS), a U.S. government program that aims to begin delivering millions of doses of a safe, effective vaccine for COVID-19 in 2021.
Novavax has been awarded $1.6 billion by the federal government to complete late-stage clinical development, including a pivotal Phase 3 clinical trial; establish large-scale manufacturing; and deliver 100 million doses of NVX‑CoV2373, Novavax’ COVID-19 vaccine candidate, as early as late 2020.
NVX‑CoV2373 consists of a stable, prefusion protein made using its proprietary nanoparticle technology and includes Novavax’ proprietary Matrix‑M™ adjuvant.
Nvax to Receive up to $388 Million Funding from CEPI CASE STUDY1. Novavax to Receive up to $388 Million Funding from CEPI for COVID-19 Vaccine Development and Manufacturing
-Funds clinical development of NVX-CoV2373 through Phase 2
-Supports rapid scale-up of vaccine manufacturing
-Allows for increased production of Matrix-M adjuvant
-Reserves global large-scale manufacturing capacity
A Phase 1/2 clinical trial with the Phase I portion starting this month in Australia and the Phase 2 portion conducted in multiple countries following successful Phase 1 top-line results that are expected in July.
ir.novavax.com
2. Novavax Reports First Quarter 2020 Financial Results
-CEPI increases investment up to $388 million for NVX‑CoV2373 vaccine development & manufacturing
-NVX‑CoV2373 Phase I trial initiating in May with preliminary results in July
-NanoFlu recently achieved all primary endpoints in pivotal Phase 3 clinical trial
ir.novavax.com
NVAX: Key Points to Look AtEarlier today, I put a target of at most $115 and later was convinced to do a sell off at $108. Many people thought this would go straight to $150+, but it looks like the positive wedge have peaked. Right now, I currently think the dip will likely be at the $90 price point, but an important factor to consider is closely monitoring movement at the $95 mark. The advanced decline ratio seems to be peaking, and the FIB retracement also showed that it was towards its high point in the morning for the current correlation trend. As always, invest in your own risk and proceed with caution. This is on an opinion based basis.
Long NVAX (Possibly day trade)As illustrated. Sell half at 1R (106.85), 1/4 at 2R. If it runs well, keep the remaining 1/4 for free run. If not, sell all.
